Benzinga's Top Initiations

Analysts at Stifel Nicolaus initiated coverage on Tokai Pharmaceuticals (NASDAQ:

) with a Buy rating. The target price for Tokai Pharmaceuticals is set to $20. Tokai Pharmaceuticals' shares closed at $11.82 on Friday. Barclays initiated coverage on shares of Foamix Pharmaceuticals (NASDAQ:

) with a Overweight rating. The target price for Foamix Pharmaceuticals is set to $11. Foamix Pharmaceuticals' shares closed at $5.08 on Friday. Analysts at Jefferies initiated coverage on shares of ProQR Therapeutics (NASDAQ:

) with a Outperform rating. The target price for ProQR Therapeutics is set to $24. ProQR Therapeutics' shares closed at $15.46 on Friday. Analysts at JMP Securities initiated coverage on A V Homes (NASDAQ:

) with a Outperform rating. The target price for A V Homes is set to $19. A V Homes' shares closed at $13.85 on Friday.